Detalhe da pesquisa
1.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Lancet
; 403(10422): 147-159, 2024 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38008109
2.
Treating chronic urticaria refractory to H1-antihistamines in Russia: data from the AWARE study.
Postepy Dermatol Alergol
; 39(3): 509-516, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35950113
3.
Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
Int Arch Allergy Immunol
; 178(3): 255-263, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30677766
4.
Comparison of biosimilar Tigerase and Pulmozyme in long-term symptomatic therapy of patients with cystic fibrosis and severe pulmonary impairment (subgroup analysis of a Phase III randomized open-label clinical trial (NCT04468100)).
PLoS One
; 16(12): e0261410, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34941914